Clinical trial
"A Pilot Study to Determine the Safety of Campath-1H (Anti-CD52) Therapy in…
NCT00365846 · University of Wisconsin, Madison, Other · Completed
Key facts
| NCT number | NCT00365846 |
|---|---|
| Title | "A Pilot Study to Determine the Safety of Campath-1H (Anti-CD52) Therapy in Primary Renal Allograft Transplantation" |
| Official title | "A Pilot Study to Determine the Safety of Campath-1H (Anti-CD52) Therapy in Primary Renal Allograft Transplantation |
| Lead sponsor | University of Wisconsin, Madison, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Renal Transplant |
| Intervention type | Drug |
| Interventions | Campath-1H |
| Enrollment | 29 |
| Start date | Aug 1, 2000 |
| Primary completion | Jul 1, 2005 |
| Completion | Jul 1, 2006 |
| First posted | Aug 18, 2006 |
| Last update posted | Oct 3, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: